{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-013326","form_type":"8-K","ticker":"CRVO","cik":"0001053691","company_name":"CervoMed Inc.","filed_at":"2022-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.526915+00:00","generated_at":"2026-06-25T07:28:45.674334+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Diffusion Pharmaceuticals appoints Raven Jaeger as Chief Regulatory Officer","bullets":["Raven Jaeger, former SVP Regulatory Affairs at BridgeBio, named Chief Regulatory Officer effective May 18, 2022.","She brings 20 years regulatory experience, including leading team to first FDA approval at BridgeBio.","Compensation: $400k base salary, 35% target bonus, $60k sign-on bonus, 8,000 stock options vesting over 36 months.","She will oversee regulatory strategy for lead candidate TSC (trans sodium crocetinate) for hypoxic solid tumors."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-013326","json":"https://secwatch.observer/filing/0001437749-22-013326.json","markdown":"https://secwatch.observer/filing/0001437749-22-013326.md","text":"https://secwatch.observer/filing/0001437749-22-013326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922013326/0001437749-22-013326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922013326/dffn20220523_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T07:28:45.674334+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2fbe0a228b","claim":"Raven Jaeger was appointed as Chief Regulatory Officer at CervoMed Inc..","evidence_excerpt":"On May 18, 2022, Raven Jaeger, M.S., was appointed as the Chief Regulatory Officer of Diffusion Pharmaceuticals Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922013326/0001437749-22-013326-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Regulatory Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}